Literature DB >> 3496893

Chylomicrons and chylomicron remnants in coronary artery disease: a case-control study.

L A Simons, T Dwyer, J Simons, L Bernstein, P Mock, N S Poonia, S Balasubramaniam, D Baron, J Branson, J Morgan.   

Abstract

Epidemiologic studies of coronary artery disease have largely overlooked the role of triglyceride-rich lipoproteins circulating in the post-prandial state. We have conducted a case-control study in males which examined fasting plasma lipoproteins and lipoproteins circulating 4 h after ingestion of a test meal containing fat and cholesterol. The cases were 82 subjects with coronary artery disease confirmed by angiography, while there were two control groups: one group of 38 'hospital controls' free of significant coronary disease by angiography, and a second group of 61 'workforce controls' free of coronary disease on historical grounds. Mean plasma and LDL cholesterol levels were significantly higher and HDL cholesterol levels were significantly lower in cases than in controls. The apo-B48/apo-B100 ratio in lipoproteins Sf greater than 60 obtained 4 h post-prandially, a relative measure of chylomicron and remnant presence, was significantly higher in cases than in controls. After pooling of all data, the prevalence of coronary artery disease was found to increase progressively with the concentration of plasma cholesterol and triglycerides, total cholesterol/HDL cholesterol ratio and the apo-B48/apo-B100 ratio in Sf greater than 60, the relative risk being highest for total cholesterol/HDL cholesterol ratio. After controlling for the confounding effects of age and other lipid factors via multiple logistic regression, apo-B48/apo-B100 ratio was still a significant predictor of coronary artery disease presence (z = 1.97, P less than 0.05) in a 'dose-response' fashion. The risk of coronary artery disease in the top quartile of apo-B48/apo-B100 distribution was 2.2-fold greater than that for the bottom quartile, after adjustment for the effects of other risk factors.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3496893     DOI: 10.1016/0021-9150(87)90020-7

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  14 in total

Review 1.  Postprandial lipemia and coronary risk.

Authors:  W Patsch; H Esterbauer; B Föger; J R Patsch
Journal:  Curr Atheroscler Rep       Date:  2000-05       Impact factor: 5.113

2.  Postprandial plasma retinyl ester response is greater in older subjects compared with younger subjects. Evidence for delayed plasma clearance of intestinal lipoproteins.

Authors:  S D Krasinski; J S Cohn; E J Schaefer; R M Russell
Journal:  J Clin Invest       Date:  1990-03       Impact factor: 14.808

3.  Apo E 2 phenotypes in type II diabetics with and without insulin therapy.

Authors:  K H Vogelberg; E Maucy
Journal:  Klin Wochenschr       Date:  1988-08-01

4.  Effects of highly purified eicosapentaenoic acid and docosahexaenoic acid on fatty acid absorption, incorporation into serum phospholipids and postprandial triglyceridemia.

Authors:  J B Hansen; S Grimsgaard; H Nilsen; A Nordøy; K H Bønaa
Journal:  Lipids       Date:  1998-02       Impact factor: 1.880

5.  Differential postprandial lipoprotein responses in type 2 diabetic men with and without clinical evidence of a former myocardial infarction.

Authors:  Marius Carstensen; Claus Thomsen; Ole Gotzsche; Jens Juul Holst; Jürgen Schrezenmeir; Kjeld Hermansen
Journal:  Rev Diabet Stud       Date:  2005-02-10

6.  Lipid peroxidation of isolated chylomicrons and oxidative status in plasma after intake of highly purified eicosapentaenoic or docosahexaenoic acids.

Authors:  J B Hansen; R K Berge; A Nordøy; K H Bønaa
Journal:  Lipids       Date:  1998-11       Impact factor: 1.880

7.  Measures of postprandial lipoproteins are not associated with coronary artery disease in patients with type 2 diabetes mellitus.

Authors:  Gissette Reyes-Soffer; Steve Holleran; Wahida Karmally; Colleen I Ngai; Niem-Tzu Chen; Margarita Torres; Rajasekhar Ramakrishnan; William S Blaner; Lars Berglund; Henry N Ginsberg; Catherine Tuck
Journal:  J Lipid Res       Date:  2009-05-08       Impact factor: 5.922

8.  Effect of glipizide treatment on postprandial lipaemia in patients with NIDDM.

Authors:  J Jeppesen; M Y Zhou; Y D Chen; G M Reaven
Journal:  Diabetologia       Date:  1994-08       Impact factor: 10.122

9.  A new ratio for better predicting future death/myocardial infarction than standard lipid measurements in women >50 years undergoing coronary angiography: the apolipoprotein A1 remnant ratio (Apo A1/ [VLDL₃+IDL]).

Authors:  Heidi T May; John R Nelson; Krishnaji R Kulkarni; Jeffrey L Anderson; Benjamin D Horne; Tami L Bair; Joseph B Muhlestein
Journal:  Lipids Health Dis       Date:  2013-04-26       Impact factor: 3.876

Review 10.  Dyslipidemia in obesity: mechanisms and potential targets.

Authors:  Boudewijn Klop; Jan Willem F Elte; Manuel Castro Cabezas
Journal:  Nutrients       Date:  2013-04-12       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.